Literature DB >> 9862667

TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site.

A I Sperling1, J R Sedy, N Manjunath, A Kupfer, B Ardman, J K Burkhardt.   

Abstract

CD43, a large highly glycosylated molecule, is arguably the most abundant molecule on the surface of T cells. Nevertheless, the function of CD43 remains unclear. Utilizing fluorescence microscopy, we find that CD43 is excluded from the T cell-APC contact site. This exclusion is Ag dependent since optimal CD43 exclusion requires Ag-pulsed APC, and since signaling through CD3, in the absence of any other receptor ligand interactions, can induce the modulation of CD43. These data suggest that CD43 may function as a barrier to nonspecific T cell-APC interactions that is removed as a result of T cell activation. Exclusion from the interaction site is a unique feature of CD43 and not universally found for all large highly glycosylated molecules since CD45 is not excluded. Thus, CD43 may represent a novel regulatory molecule on the T cell surface that can direct T cell interactions by changing its location on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862667

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  Signaling through sphingolipid microdomains of the plasma membrane: the concept of signaling platform.

Authors:  D C Hoessli; S Ilangumaran; A Soltermann; P J Robinson; B Borisch
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

Review 2.  Imaging T-cell antigen recognition and comparing immunological and neuronal synapses.

Authors:  E Donnadieu; P Revy; A Trautmann
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

3.  CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO.

Authors:  T Ishii; K Ohnuma; A Murakami; N Takasawa; S Kobayashi; N H Dang; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

4.  EMBO WORKSHOP REPORT: lymphocyte antigen receptor and coreceptor signaling Siena, Italy, November 6-10, 1999.

Authors:  C T Baldari; J L Telford; O Acuto
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

5.  Ezrin tunes T-cell activation by controlling Dlg1 and microtubule positioning at the immunological synapse.

Authors:  Rémi Lasserre; Stéphanie Charrin; Céline Cuche; Anne Danckaert; Maria-Isabel Thoulouze; Fabrice de Chaumont; Tarn Duong; Nathalie Perrault; Nadine Varin-Blank; Jean-Christophe Olivo-Marin; Sandrine Etienne-Manneville; Monique Arpin; Vincenzo Di Bartolo; Andrés Alcover
Journal:  EMBO J       Date:  2010-06-15       Impact factor: 11.598

6.  Quantitative imaging of lymphocyte membrane protein reorganization and signaling.

Authors:  Peter M Kasson; Johannes B Huppa; Michelle Krogsgaard; Mark M Davis; Axel T Brunger
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

7.  T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster.

Authors:  Rajat Varma; Gabriele Campi; Tadashi Yokosuka; Takashi Saito; Michael L Dustin
Journal:  Immunity       Date:  2006-07       Impact factor: 31.745

8.  Signaling through CD43 regulates CD4 T-cell trafficking.

Authors:  Purvi D Mody; Judy L Cannon; Hozefa S Bandukwala; Kelly M Blaine; Alexander B Schilling; Kevin Swier; Anne I Sperling
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

9.  LFA-1-mediated T cell costimulation through increased localization of TCR/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse.

Authors:  Beth Graf; Timothy Bushnell; Jim Miller
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

10.  Age-related defects in moesin/ezrin cytoskeletal signals in mouse CD4 T cells.

Authors:  Gonzalo G Garcia; Amir A Sadighi Akha; Richard A Miller
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.